Wesley Pharmaceuticals Expands Longevity Portfolio with Launch of Three Essential Injectable Formulations

▤ Summary

Wesley Pharmaceuticals has launched three injectable formulations: Methylcobalamin, Glutathione, and Magnesium Chloride. The company says the new multi-dose vials expand clinical flexibility and support longer treatment continuity for providers. It positions the products as 503(b)-compliant options for longevity, metabolic health, antioxidant support, and magnesium deficiency care. The launch gives healthcare providers a new supply source for therapies they already use in office-based and IV treatment protocols.

▦ Linked Companies